Nearly 3 million Americans suffer from treatment-resistant depression, meaning antidepressants simply don’t work for them. Motif Neurotech wants to change that with a tiny brain implant, and the FDA has just greenlighted a human trial to test it.
As reported by Wired, the Houston-based startup has developed a tiny device that sits in the skull, just above the brain’s protective membrane. It targets the part of the brain responsible for high-level thinking that tends to go quiet in people with major depressive disorder. The implant delivers precise electrical pulses to wake that network back up.
The best part? The whole procedure takes only 20 minutes and doesn’t require traditional brain surgery.
So how does this actually work?
Once implanted, the device is powered wirelessly. Patients charge and control it using a baseball cap that sends stimulation data directly to the implant. You wear the cap for 10 to 20 minutes, several times a day, and that’s your treatment.
Jacob Robinson, Motif’s cofounder and CEO, says patients could start seeing results within the first 10 days. After that, the cap becomes a maintenance tool rather than a daily ritual.
Is electrical stimulation for the brain anything new?
Not really. Electroconvulsive therapy has been around since the 1930s, and transcranial magnetic stimulation has been FDA-approved since 2008. But existing treatments are either too intense or too time-consuming, often requiring multiple weekly sessions at a clinic for six weeks.
The current trial will enroll around 10 participants and run over 12 months, primarily to confirm the implant’s safety. Researchers will also track changes in depression symptoms, anxiety, and quality of life throughout.
Future versions of the device are planned to monitor brain activity over time, opening the door to truly personalized treatment. I hope the company succeeds at its ventures and ushers in a new era of depression treatment.
Stephan is the sports journalist for the Maple Grove Report.
